The latter is a conserved single-pass transmembrane receptor, crucial to T-cell lineage commitment and itself a major T-ALL target, given that activating NOTCH1 mutants are common in T-ALL (161). This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.